AVXL
ANAVEX LIFE SCIENCES CORP.
Company overview
- Market capitalization
- $217.78M
- Employees
- 34
- Latest publication
- 2026-09-29
About ANAVEX LIFE SCIENCES CORP.
Anavex Life Sciences Corp. operates as a biopharmaceutical company. It engages in developing innovative treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders, pain, and various types of cancer . Its lead drug candidate, ANAVEX 2-73 (blarcamesine), has completed a Phase 2a and a Phase 2b/3 clinical trial for Alzheimer's disease; a Phase 2 proof-of-concept study in Parkinson's disease dementia; and a Phase 2 and a Phase 3 study in adult patients and one Phase 2/3 study in pediatric patients with Rett syndrome. Its ANAVEX 2-73 is an orally available drug candidate designed to restore cellular homeostasis by targeting SIGMAR1 and muscarinic receptors. The ANAVEX 2-73 also exhibited anticonvulsant, anti-amnesic, neuroprotective, and anti-depressant properties in animal models, indicating its potential to treat additional CNS disorders, including epilepsy. The company's ANAVEX 3-71, which targets SIGMAR1 and M1 muscarinic receptors, is a clinical stage drug candidate demonstrating disease-modifying activity against Alzheimer's disease in transgenic (3xTg-AD) mice, including cognitive deficits, amyloid, and tau pathologies. Anavex Life Sciences Corp. was incorporated in 2004 and is headquartered in New York, New York.
Financial statements
Income Quarterly
| Metric | Q3 20262026-06-30 · USD | Q1 20262025-12-31 · USD | Q4 20252025-09-30 · USD | Q3 20252025-06-30 · USD | Q2 20252025-03-31 · USD | Q1 20252024-12-31 · USD | Q4 20242024-09-30 · USD | Q3 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total operating expenses (recovery) | -6,737,000USD | — | — | — | — | — | — | — |
| Basic | 92,696,842,000shares | — | — | — | — | — | — | — |
| Income (loss) | 7,824,000USD | — | — | — | — | — | — | — |
| Diluted | 92,899,536,000shares | — | — | — | — | — | — | — |
| Income (Loss) from operations | 6,737,000USD | — | — | — | — | — | — | — |
| General and administrative (recovery) | -2,032,000USD | — | — | — | — | — | — | — |
| Total other income, net | 1,087,000USD | — | — | — | — | — | — | — |
| Research and development (recovery) | -4,705,000USD | — | — | — | — | — | — | — |
| Total Revenue | — | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Research Development | — | 4,656,000USD | 7,294,000USD | 9,959,000USD | 9,892,000USD | 10,446,000USD | 11,555,000USD | 11,811,000USD |
| Selling General Administrative | — | 2,126,000USD | 3,550,000USD | 4,500,000USD | 2,621,000USD | 3,146,000USD | 2,781,000USD | 2,792,000USD |
| Total Operating Expenses | — | 6,782,000USD | 10,844,000USD | 14,459,000USD | 12,513,000USD | 13,592,000USD | 14,336,000USD | 14,603,000USD |
| Operating Income | — | -6,782,000USD | -10,844,000USD | -14,459,000USD | -12,513,000USD | -13,592,000USD | -14,336,000USD | -14,603,000USD |
| Interest Income | — | 1,079,000USD | 999,000USD | 1,075,000USD | 1,210,000USD | 1,394,000USD | 1,759,000USD | 1,796,000USD |
| Net Interest Income | — | 1,079,000USD | 999,000USD | 1,075,000USD | 1,210,000USD | 1,394,000USD | 1,759,000USD | 1,796,000USD |
| Income Before Tax | — | -5,663,000USD | -9,827,000USD | -13,243,000USD | -11,196,000USD | -12,111,000USD | -11,744,000USD | -12,214,000USD |
| Income Tax Expense | — | 18,000USD | — | -127,000USD | -96,000USD | -412,000USD | -124,000USD | -67,000USD |
| Tax Provision | — | 18,000USD | — | — | — | 0USD | -124,000USD | -67,000USD |
| Net Income | — | -5,681,000USD | -9,827,000USD | -13,243,000USD | -11,196,000USD | -12,111,000USD | -11,620,000USD | -12,214,000USD |
| Net Income From Continuing Ops | — | -5,681,000USD | -9,827,000USD | -13,243,000USD | -11,196,000USD | -12,111,000USD | -11,620,000USD | -12,214,000USD |
| Ebitda | — | -5,663,000USD | -6,485,000USD | -14,307,000USD | -12,417,000USD | -13,580,000USD | -11,744,000USD | -14,077,000USD |
| Total Other Income Expense Net | — | 1,119,000USD | 1,017,000USD | 1,216,000USD | 1,317,000USD | 1,481,000USD | 2,592,000USD | 2,389,000USD |
| Ebit | — | — | — | — | -11,292,000USD | -12,523,000USD | -11,271,000USD | -26,471,000USD |
| Depreciation And Amortization | — | — | — | — | 12,417,000USD | 1,057,000USD | -22,748,000USD | 14,203,000USD |
| Interest Expense | — | — | — | — | — | — | 0USD | 0USD |
| Source | DisclosurePreliminary | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-09-30 · USD | FY 20232023-09-30 · USD | FY 20222022-09-30 · USD | FY 20212021-09-30 · USD | FY 20202020-09-30 · USD | FY 20192019-09-30 · USD | FY 20182018-09-30 · USD | FY 20172017-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | -685,000USD | 0USD | 0USD |
| Research Development | 37,592,000USD | 43,717,000USD | 37,916,000USD | 32,984,000USD | 25,231,623USD | 22,260,349USD | 13,344,421USD | 10,672,086USD |
| Selling General Administrative | 13,816,000USD | 12,039,000USD | 13,070,000USD | 9,018,000USD | 5,856,609USD | 6,846,599USD | 5,989,170USD | 5,008,275USD |
| Total Operating Expenses | 51,408,000USD | 55,756,000USD | 50,986,000USD | 42,002,000USD | 30,938,344USD | 28,808,005USD | 19,184,536USD | 15,539,419USD |
| Operating Income | -51,408,000USD | -47,498,000USD | -50,986,000USD | -42,002,000USD | -31,088,232USD | -28,752,000USD | -19,185,000USD | -15,539,000USD |
| Interest Income | 4,678,000USD | 6,519,000USD | 946,988USD | 26,261USD | 179,973USD | 207,280USD | 255,092USD | 88,098USD |
| Interest Expense | 0USD | 964,000USD | 946,988USD | 4,038,672USD | 4,806,078USD | 151,133USD | 30,943USD | 0USD |
| Net Interest Income | 4,678,000USD | 5,555,000USD | 946,988USD | 26,261USD | 179,973USD | 56,147USD | 224,149USD | 88,098USD |
| Income Before Tax | -46,377,000USD | -47,498,000USD | -47,620,000USD | -37,641,000USD | -26,257,806USD | -26,212,798USD | -17,380,663USD | -13,400,798USD |
| Income Tax Expense | -648,000USD | -7,000USD | 358,000USD | 268,000USD | 22,664USD | 82,181USD | 72,746USD | 59,607USD |
| Net Income | -46,377,000USD | -47,491,000USD | -47,978,000USD | -37,909,000USD | -26,280,470USD | -26,294,979USD | -17,453,409USD | -13,460,405USD |
| Net Income From Continuing Ops | -46,377,000USD | -47,505,000USD | -47,977,919USD | -37,908,634USD | -26,280,470USD | -26,294,979USD | -17,453,409USD | -13,460,405USD |
| Ebitda | -46,377,000USD | -47,498,000USD | -47,620,000USD | -37,641,000USD | -31,063,884USD | -28,881,374USD | -19,134,747USD | -15,567,040USD |
| Total Other Income Expense Net | 5,031,000USD | 2,678,000USD | 3,366,000USD | 4,361,000USD | 4,500,565USD | 2,539,060USD | 1,579,724USD | 2,050,523USD |
| Selling And Marketing Expenses | — | 118,000USD | 73,000USD | 131,000USD | — | — | 151,405USD | 127,993USD |
| Tax Provision | — | 7,000USD | 358,492USD | 267,565USD | 22,664USD | 82,181USD | 72,746USD | 59,607USD |
| Ebit | — | -47,498,000USD | -47,619,000USD | -74,830,000USD | -57,777,000USD | -55,522,000USD | -36,638,000USD | -15,568,252USD |
| Depreciation And Amortization | — | -2,718USD | -3,323,000USD | 37,455,000USD | 26,713,000USD | 26,641,000USD | 17,503,000USD | 1,252USD |
| Net Income Applicable To Common Shares | — | -47,505,000USD | -47,977,919USD | -37,908,634USD | -26,280,470USD | -26,294,979USD | -17,252,736USD | -13,460,405USD |
| Non Operating Income Net Other | — | — | 2,419,400USD | 4,333,855USD | 4,650,453USD | 2,686,870USD | 1,697,836USD | 2,191,465USD |
| Cost Of Revenue | — | — | — | — | — | — | 0USD | 0USD |
| Gross Profit | — | — | — | — | — | — | 0USD | 0USD |
| Reconciled Depreciation | — | — | — | — | — | — | 0USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q3 20262026-06-30 · USD | Q2 20262026-03-31 · USD | Q1 20262025-12-31 · USD | Q4 20252025-09-30 · USD | Q3 20252025-06-30 · USD | Q2 20252025-03-31 · USD | Q1 20252024-12-31 · USD | Q4 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 120,139,000USD | 128,766,000USD | 132,989,000USD | 103,815,000USD | 102,432,000USD | 117,139,000USD | 124,043,000USD | 135,567,000USD |
| Cash And Equivalents | 118,326,000USD | 127,422,000USD | — | 102,577,000USD | — | — | — | — |
| Other Current Assets | 818,000USD | 412,000USD | 396,000USD | 429,000USD | -820,000USD | 702,000USD | 711,000USD | 931,000USD |
| Total Liabilities | 7,692,000USD | 7,059,000USD | — | 8,946,000USD | — | — | — | — |
| Other Current Liabilities | 4,036,000USD | 3,734,000USD | — | 3,892,000USD | — | — | — | — |
| Total Stockholder Equity | 112,447,000USD | 121,707,000USD | 126,618,000USD | 94,869,000USD | 90,958,000USD | 99,758,000USD | 110,915,000USD | 120,263,000USD |
| Total Equity Including Noncontrolling Interest | 112,447,000USD | 121,707,000USD | — | 94,869,000USD | — | — | — | — |
| Accounts Payable | 3,656,000USD | 2,520,000USD | 2,639,000USD | 4,249,000USD | 6,740,000USD | 6,997,000USD | 4,567,000USD | 9,627,000USD |
| Common Stock | 93,000USD | 93,000USD | 93,000USD | 87,000USD | 85,000USD | 85,000USD | 85,000USD | 85,000USD |
| Retained Earnings | -385,643,000USD | -393,467,000USD | -388,129,000USD | -382,448,000USD | -372,621,000USD | -359,378,000USD | -348,182,000USD | -336,071,000USD |
| Total Liab | — | — | 6,371,000USD | — | 11,474,000USD | 17,381,000USD | 13,128,000USD | 15,304,000USD |
| Other Current Liab | — | — | 2,927,000USD | — | 3,929,000USD | 9,555,000USD | 7,732,000USD | 4,835,000USD |
| Capital Stock | — | — | 93,000USD | — | 85,000USD | 85,000USD | 85,000USD | 85,000USD |
| Cash | — | — | 131,749,000USD | — | 101,164,000USD | 115,771,000USD | 120,775,000USD | 132,187,000USD |
| Cash And Short Term Investments | — | — | 131,749,000USD | — | 101,164,000USD | 115,771,000USD | 120,775,000USD | 132,187,000USD |
| Total Current Assets | — | — | 132,989,000USD | — | 101,164,000USD | 117,139,000USD | 124,043,000USD | 135,567,000USD |
| Total Current Liabilities | — | — | 6,371,000USD | — | 11,474,000USD | 17,381,000USD | 13,128,000USD | 15,304,000USD |
| Current Deferred Revenue | — | — | 805,000USD | — | 805,000USD | 829,000USD | 829,000USD | 842,000USD |
| Net Debt | — | — | -131,749,000USD | — | -101,164,000USD | -115,771,000USD | -120,775,000USD | -132,187,000USD |
| Net Receivables | — | — | 844,000USD | — | 820,000USD | 666,000USD | 2,557,000USD | 2,449,000USD |
| Common Stock Shares Outstanding | — | — | 89,029,458shares | — | 85,380,587shares | 85,073,769shares | 84,806,000shares | 84,002,000shares |
| Non Current Assets Total | — | — | 0USD | — | 0USD | 0USD | 0USD | 3,380,000USD |
| Non Current Liabilities Total | — | — | 2,927,000USD | — | 3,929,000USD | 9,555,000USD | 7,732,000USD | 4,835,000USD |
| Net Working Capital | — | — | 126,618,000USD | — | 90,958,000USD | 99,758,000USD | 110,915,000USD | 120,263,000USD |
| Unclassified Non Current Liabilities | — | — | 2,927,000USD | — | 3,929,000USD | 9,555,000USD | 7,732,000USD | 4,835,000USD |
| Unclassified Equity | — | — | 514,561,000USD | — | 463,409,000USD | 458,966,000USD | 458,927,000USD | 456,164,000USD |
| Other Assets | — | — | — | — | 1,268,000USD | 1,368,000USD | 3,268,000USD | — |
| Unclassified Non Current Assets | — | — | — | — | -1,268,000USD | -1,368,000USD | -3,268,000USD | 3,380,000USD |
| Source | DisclosureDeterministicFinal | DisclosureDeterministicFinal | Legacy providerLegacy | DisclosureDeterministicAmendment | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-09-30 · USD | FY 20242024-09-30 · USD | FY 20232023-09-30 · USD | FY 20222022-09-30 · USD | FY 20212021-09-30 · USD | FY 20202020-09-30 · USD | FY 20192019-09-30 · USD | FY 20182018-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 103,815,000USD | 135,567,000USD | 154,386,000USD | 152,704,603USD | 161,616,490USD | 34,542,197USD | 25,329,373USD | 24,376,136USD |
| Cash And Equivalents | 102,577,000USD | — | — | — | — | — | — | — |
| Other Current Assets | 429,000USD | 931,000USD | 653,000USD | 354,162USD | 355,549USD | 443,839USD | 3,143,743USD | 1,251,798USD |
| Total Liabilities | 8,946,000USD | — | — | — | — | — | — | — |
| Other Current Liabilities | 3,892,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 94,869,000USD | 120,263,000USD | 141,852,000USD | 142,491,042USD | 150,818,104USD | 27,236,569USD | 20,289,699USD | 20,491,510USD |
| Total Equity Including Noncontrolling Interest | 94,869,000USD | — | — | — | — | — | — | — |
| Accounts Payable | 4,249,000USD | 9,627,000USD | 4,322,000USD | 3,824,777USD | 4,739,781USD | 3,989,054USD | 3,523,332USD | 2,955,293USD |
| Common Stock | 87,000USD | 85,000USD | 82,000USD | 77,944USD | 75,920USD | 62,047USD | 52,652USD | 45,935USD |
| Retained Earnings | -382,448,000USD | -336,071,000USD | -293,069,000USD | -245,563,783USD | -197,585,864USD | -159,677,230USD | -133,396,760USD | -108,931,967USD |
| Total Liab | — | 15,304,000USD | 12,534,000USD | 10,214,000USD | 10,798,386USD | 7,305,628USD | 5,039,674USD | 3,884,626USD |
| Other Current Liab | — | 4,835,000USD | 7,295,000USD | 5,944,953USD | 5,614,774USD | 3,316,574USD | 1,516,342USD | 929,333USD |
| Capital Stock | — | 85,000USD | 82,000USD | 77,944USD | 75,920USD | 62,047USD | 52,652USD | 45,935USD |
| Other Assets | — | 3,380,000USD | -3,362,000USD | -3,546,742,000USD | -16,365USD | -5,293,179USD | — | 153,529USD |
| Cash | — | 132,187,000USD | 151,024,000USD | 149,157,861USD | 152,107,745USD | 29,249,018USD | 22,185,630USD | 22,930,638USD |
| Cash And Short Term Investments | — | 132,187,000USD | 151,024,000USD | 149,157,861USD | 152,107,745USD | 29,249,018USD | 22,185,630USD | 22,930,638USD |
| Total Current Assets | — | 135,567,000USD | 154,386,000USD | 152,704,603USD | 161,616,490USD | 34,542,197USD | 25,329,373USD | 24,323,740USD |
| Total Current Liabilities | — | 15,304,000USD | 12,534,000USD | 10,213,561USD | 10,798,386USD | 7,305,628USD | 5,039,674USD | 3,884,626USD |
| Current Deferred Revenue | — | 842,000USD | 917,000USD | 443,831USD | 443,831USD | — | — | — |
| Net Debt | — | -132,187,000USD | -151,024,000USD | -149,157,861USD | -152,107,745USD | -29,249,018USD | -22,185,630USD | -22,930,638USD |
| Net Receivables | — | 2,449,000USD | 2,709,000USD | 3,193,000USD | 9,136,831USD | 4,849,340USD | 2,642,745USD | 1,870,357USD |
| Common Stock Shares Outstanding | — | 83,468,000shares | 79,788,000shares | 76,910,000shares | 69,803,000shares | 58,195,000shares | 48,906,000shares | 44,656,000shares |
| Non Current Assets Total | — | 0USD | 3,362,000USD | 3,546,742,000USD | 16,365USD | 5,293,179USD | 0USD | 52,396USD |
| Non Current Liabilities Total | — | 4,835,000USD | 7,295,000USD | 4,268,608USD | -386USD | 3,316,574USD | 1,516,342USD | 0USD |
| Net Working Capital | — | 120,263,000USD | 141,852,000USD | 142,491,042USD | 150,818,104USD | 27,236,569USD | 20,289,699USD | 20,439,114USD |
| Unclassified Non Current Assets | — | -3,380,000USD | — | — | — | — | — | — |
| Unclassified Non Current Liabilities | — | 4,835,000USD | 7,295,000USD | 3,824,777USD | — | 3,316,574USD | 1,516,342USD | — |
| Unclassified Equity | — | 456,164,000USD | 434,757,000USD | 387,898,937USD | 348,252,128USD | 186,789,705USD | 153,581,155USD | 129,331,607USD |
| Accumulated Other Comprehensive Income | — | — | 0USD | 0USD | 0USD | — | — | 0USD |
| Non Currrent Assets Other | — | — | 3,362,000USD | 3,546,742,000USD | 16,365USD | 5,293,179USD | 0USD | 52,396USD |
| Net Tangible Assets | — | — | 141,852,000USD | 142,491,042USD | 150,818,104USD | 27,236,569USD | 20,289,699USD | 22,321,696USD |
| Deferred Long Term Liab | — | — | — | 443,831USD | 443,831USD | — | — | 101,133USD |
| Inventory | — | — | — | — | 16,365USD | — | -2,642,745USD | 0USD |
| Unclassified Current Assets | — | — | — | — | — | — | -2,642,745USD | -1,729,053USD |
| Intangible Assets | — | — | — | — | — | — | — | 0USD |
| Good Will | — | — | — | — | — | — | — | 0USD |
| Long Term Debt | — | — | — | — | — | — | — | 0USD |
| Short Term Investments | — | — | — | — | — | — | — | 0USD |
| Property Plant Equipment Net | — | — | — | — | — | — | — | 0USD |
| Additional Paid In Capital | — | — | — | — | — | — | — | 0USD |
| Treasury Stock | — | — | — | — | — | — | — | 0USD |
| Source | DisclosureDeterministicAmendment | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q3 20262026-06-30 · USD | Q2 20262026-03-31 · USD |
|---|---|---|
| Stock Based Compensation | -15,663,000USD | 1,421,000USD |
| Change To Liabilities | -1,254,000USD | -1,887,000USD |
| Change In Working Capital | -593,000USD | -1,729,000USD |
| Operating Cash Flow | -20,687,000USD | -11,591,000USD |
| Financing Cash Flow | 36,436,000USD | 36,436,000USD |
| Change In Cash | 15,749,000USD | 24,845,000USD |
| End Cash Flow | 118,326,000USD | 127,422,000USD |
| Source | DisclosureDeterministicFinal | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262025-12-31 · USD | Q4 20252025-09-30 · USD | Q3 20252025-06-30 · USD | Q2 20252025-03-31 · USD | Q1 20252024-12-31 · USD | Q4 20242024-09-30 · USD | Q3 20242024-06-30 · USD | Q2 20242024-03-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -5,681,000USD | -9,827,000USD | -13,243,000USD | -11,196,000USD | -12,111,000USD | -11,620,000USD | -12,214,000USD | -10,546,000USD |
| Stock Based Compensation | 1,107,000USD | 3,721,000USD | 4,324,000USD | 1,449,000USD | 2,055,000USD | 2,013,000USD | 2,487,000USD | 2,652,000USD |
| Change To Account Receivables | -35,000USD | 11,000USD | -154,000USD | 1,891,000USD | -108,000USD | -729,000USD | 2,065,000USD | -236,000USD |
| Change In Working Capital | -2,577,000USD | -2,498,000USD | -3,545,000USD | 3,891,000USD | -2,064,000USD | 2,890,000USD | 4,606,000USD | -3,762,000USD |
| Total Cash From Operating Activities | -7,151,000USD | -8,604,000USD | -12,464,000USD | -5,856,000USD | -12,120,000USD | -6,658,000USD | -5,180,000USD | -11,656,000USD |
| Capital Expenditures | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Free Cash Flow | -7,151,000USD | -8,604,000USD | -12,464,000USD | -5,856,000USD | -12,120,000USD | -6,658,000USD | -5,180,000USD | -11,656,000USD |
| Total Cash From Financing Activities | 36,323,000USD | 10,017,000USD | -2,143,000USD | 852,000USD | 708,000USD | 89,000USD | 4,550,000USD | 7,277,000USD |
| Issuance Of Capital Stock | 36,323,000USD | 9,198,000USD | 0USD | 0USD | 0USD | 0USD | 4,106,000USD | — |
| Change In Cash | 29,172,000USD | 1,413,000USD | -14,607,000USD | -5,004,000USD | -11,412,000USD | -6,569,000USD | -630,000USD | -4,379,000USD |
| Begin Period Cash Flow | 102,577,000USD | 101,164,000USD | 115,771,000USD | 120,775,000USD | 132,187,000USD | 138,756,000USD | 139,386,000USD | 143,765,000USD |
| End Period Cash Flow | 131,749,000USD | 102,577,000USD | 101,164,000USD | 115,771,000USD | 120,775,000USD | 132,187,000USD | 138,756,000USD | 139,386,000USD |
| Other Cashflows From Financing Activities | — | -445,000USD | -2,262,000USD | 852,000USD | 708,000USD | 89,000USD | 444,000USD | 7,277,000USD |
| Unclassified Financing Cash Flow | — | 1,264,000USD | — | — | — | — | — | — |
| Other Non Cash Items | — | — | — | 1,827,000USD | — | 59,000USD | -59,000USD | 3,454,000USD |
| Unclassified Operating Cash Flow | — | — | — | -1,827,000USD | — | — | — | -3,454,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-09-30 · USD | FY 20242024-09-30 · USD | FY 20232023-09-30 · USD | FY 20222022-09-30 · USD | FY 20212021-09-30 · USD | FY 20202020-09-30 · USD | FY 20192019-09-30 · USD | FY 20182018-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Stock Based Compensation | 11,549,000USD | 9,438,000USD | 16,370,000USD | 18,379,000USD | 8,231,000USD | 4,876,906USD | 6,430,873USD | 5,517,004USD |
| Change To Liabilities | -6,321,000USD | — | 970,000USD | -915,004USD | 1,194,558USD | 2,265,954USD | 1,270,806USD | 300,292USD |
| Change In Working Capital | -5,378,000USD | 2,752,000USD | 2,505,000USD | 5,361,000USD | -706,000USD | 116,518USD | 1,301,614USD | -846,674USD |
| Operating Cash Flow | -39,044,000USD | — | — | — | — | — | — | — |
| Financing Cash Flow | 9,434,000USD | — | — | — | — | — | — | — |
| Change In Cash | -29,610,000USD | -18,837,000USD | 1,866,000USD | -2,950,000USD | 122,859,000USD | 7,063,388USD | -745,008USD | -4,509,619USD |
| End Cash Flow | 102,577,000USD | — | — | — | — | — | — | — |
| Net Income | — | -43,002,000USD | -47,505,000USD | -47,978,000USD | -37,909,000USD | -26,280,470USD | -26,294,979USD | -17,252,736USD |
| Other Non Cash Items | — | 2,752,000USD | 845,000USD | 242USD | 403USD | 6,617,779USD | 35,375USD | 5,608,734USD |
| Change To Account Receivables | — | 260,000USD | 484,000USD | 5,944,000USD | -4,287,000USD | -2,206,595USD | -772,388USD | -231,096USD |
| Total Cash From Operating Activities | — | -30,812,000USD | -27,785,000USD | -24,238,000USD | -30,384,000USD | -21,287,046USD | -18,527,117USD | -12,582,406USD |
| Capital Expenditures | — | 0USD | 0USD | -4USD | -4USD | -4USD | 0USD | 0USD |
| Free Cash Flow | — | -30,812,000USD | -27,785,000USD | -24,238,000USD | -30,384,000USD | -21,287,046USD | -18,527,117USD | -12,582,406USD |
| Total Cash From Financing Activities | — | 11,975,000USD | 29,651,000USD | 21,288,000USD | 153,243,000USD | 28,350,434USD | 17,782,109USD | 8,072,787USD |
| Issuance Of Capital Stock | — | 11,284,000USD | 27,875,000USD | 20,984,667USD | 153,218,762USD | 28,754,198USD | 17,832,109USD | 8,173,920USD |
| Begin Period Cash Flow | — | 151,024,000USD | 149,158,000USD | 152,108,000USD | 29,249,000USD | 22,185,630USD | 22,930,638USD | 27,440,257USD |
| End Period Cash Flow | — | 132,187,000USD | 151,024,000USD | 149,158,000USD | 152,108,000USD | 29,249,018USD | 22,185,630USD | 22,930,638USD |
| Other Cashflows From Financing Activities | — | 11,975,000USD | 29,651,000USD | -707,000USD | 24,000USD | -403,764USD | -50,000USD | -101,133USD |
| Unclassified Operating Cash Flow | — | -2,752,000USD | — | — | — | -6,617,779USD | — | -5,608,734USD |
| Unclassified Financing Cash Flow | — | -11,284,000USD | -27,875,000USD | — | — | — | — | — |
| Change To Inventory | — | — | -484,000USD | -5,944,251USD | 4,287,491USD | 2,206,595USD | 772,388USD | 0USD |
| Sale Purchase Of Stock | — | — | — | 21,287,980USD | 153,242,401USD | 28,350,434USD | 17,832,109USD | 8,173,920USD |
| Cash And Cash Equivalents Changes | — | — | — | -2,949,884USD | 122,858,727USD | 7,063,388USD | -745,008USD | -4,509,619USD |
| Net Borrowings | — | — | — | — | — | — | -50,000USD | -101,133USD |
| Depreciation | — | — | — | — | — | — | — | 0USD |
| Total Cashflows From Investing Activities | — | — | — | — | — | — | — | 0USD |
| Dividends Paid | — | — | — | — | — | — | — | 0USD |
| Other Cashflows From Investing Activities | — | — | — | — | — | — | — | 0USD |
| Source | DisclosureDeterministicAmendment | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.